nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CYP3A4—Bexarotene—hematologic cancer	0.0315	0.0829	CbGbCtD
Isradipine—CYP3A4—Lomustine—hematologic cancer	0.0293	0.0771	CbGbCtD
Isradipine—CYP3A4—Busulfan—hematologic cancer	0.0293	0.0771	CbGbCtD
Isradipine—CYP3A4—Thiotepa—hematologic cancer	0.0261	0.0687	CbGbCtD
Isradipine—CYP3A4—Methoxsalen—hematologic cancer	0.0203	0.0534	CbGbCtD
Isradipine—CYP3A4—Bortezomib—hematologic cancer	0.0193	0.0508	CbGbCtD
Isradipine—CYP3A4—Daunorubicin—hematologic cancer	0.0185	0.0486	CbGbCtD
Isradipine—CYP3A4—Cytarabine—hematologic cancer	0.0163	0.0429	CbGbCtD
Isradipine—CYP3A4—Teniposide—hematologic cancer	0.016	0.0422	CbGbCtD
Isradipine—CYP3A4—Ifosfamide—hematologic cancer	0.0148	0.039	CbGbCtD
Isradipine—CYP3A4—Imatinib—hematologic cancer	0.0141	0.0372	CbGbCtD
Isradipine—CYP3A4—Ruxolitinib—hematologic cancer	0.0133	0.0351	CbGbCtD
Isradipine—CYP3A4—Nilotinib—hematologic cancer	0.0128	0.0338	CbGbCtD
Isradipine—CYP3A4—Vinorelbine—hematologic cancer	0.0127	0.0335	CbGbCtD
Isradipine—CYP3A4—Triamcinolone—hematologic cancer	0.0117	0.0307	CbGbCtD
Isradipine—CYP3A4—Dasatinib—hematologic cancer	0.0114	0.0299	CbGbCtD
Isradipine—CYP3A4—Mitoxantrone—hematologic cancer	0.0112	0.0295	CbGbCtD
Isradipine—CYP3A4—Betamethasone—hematologic cancer	0.01	0.0263	CbGbCtD
Isradipine—CYP3A4—Prednisolone—hematologic cancer	0.00987	0.026	CbGbCtD
Isradipine—CYP3A4—Prednisone—hematologic cancer	0.00932	0.0245	CbGbCtD
Isradipine—CYP3A4—Irinotecan—hematologic cancer	0.00883	0.0233	CbGbCtD
Isradipine—CYP3A4—Vinblastine—hematologic cancer	0.00785	0.0207	CbGbCtD
Isradipine—CYP3A4—Vincristine—hematologic cancer	0.00772	0.0203	CbGbCtD
Isradipine—CYP3A4—Etoposide—hematologic cancer	0.00707	0.0186	CbGbCtD
Isradipine—CYP3A4—Dexamethasone—hematologic cancer	0.00582	0.0153	CbGbCtD
Isradipine—CYP3A4—Doxorubicin—hematologic cancer	0.00482	0.0127	CbGbCtD
Isradipine—CACNA1H—gonad—hematologic cancer	0.00242	0.0773	CbGeAlD
Isradipine—CACNA2D2—lung—hematologic cancer	0.00228	0.0728	CbGeAlD
Isradipine—CACNA2D2—testis—hematologic cancer	0.00215	0.0687	CbGeAlD
Isradipine—CACNA2D1—bone marrow—hematologic cancer	0.00181	0.0578	CbGeAlD
Isradipine—CACNB2—lung—hematologic cancer	0.00175	0.0557	CbGeAlD
Isradipine—CACNA1H—testis—hematologic cancer	0.00175	0.0557	CbGeAlD
Isradipine—CACNB2—testis—hematologic cancer	0.00165	0.0526	CbGeAlD
Isradipine—CACNA2D1—lung—hematologic cancer	0.00164	0.0523	CbGeAlD
Isradipine—CACNA2D2—lymph node—hematologic cancer	0.00156	0.0498	CbGeAlD
Isradipine—CACNA2D1—testis—hematologic cancer	0.00155	0.0494	CbGeAlD
Isradipine—CACNA1D—lung—hematologic cancer	0.00153	0.0487	CbGeAlD
Isradipine—CACNA1D—testis—hematologic cancer	0.00144	0.046	CbGeAlD
Isradipine—CACNA1C—lung—hematologic cancer	0.00141	0.045	CbGeAlD
Isradipine—CACNA1C—testis—hematologic cancer	0.00133	0.0424	CbGeAlD
Isradipine—CACNA1H—lymph node—hematologic cancer	0.00127	0.0404	CbGeAlD
Isradipine—CACNB2—lymph node—hematologic cancer	0.0012	0.0381	CbGeAlD
Isradipine—CACNA2D1—lymph node—hematologic cancer	0.00112	0.0358	CbGeAlD
Isradipine—CACNA1D—lymph node—hematologic cancer	0.00104	0.0333	CbGeAlD
Isradipine—CACNA1C—lymph node—hematologic cancer	0.000965	0.0308	CbGeAlD
Isradipine—CYP3A4—hematopoietic system—hematologic cancer	0.000897	0.0286	CbGeAlD
Isradipine—Nifedipine—ABCC3—hematologic cancer	0.000683	0.42	CrCbGaD
Isradipine—CYP3A4—blood—hematologic cancer	0.000594	0.0189	CbGeAlD
Isradipine—Nisoldipine—ABCB1—hematologic cancer	0.000192	0.118	CrCbGaD
Isradipine—Nitrendipine—ABCB1—hematologic cancer	0.000179	0.11	CrCbGaD
Isradipine—Amlodipine—ABCB1—hematologic cancer	0.000154	0.095	CrCbGaD
Isradipine—Felodipine—ABCB1—hematologic cancer	0.000143	0.0878	CrCbGaD
Isradipine—Nifedipine—ABCB1—hematologic cancer	0.000138	0.085	CrCbGaD
Isradipine—Nicardipine—ABCB1—hematologic cancer	0.000136	0.0836	CrCbGaD
Isradipine—Discomfort—Prednisone—hematologic cancer	6.95e-05	0.000164	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—hematologic cancer	6.95e-05	0.000164	CcSEcCtD
Isradipine—Rash—Gemcitabine—hematologic cancer	6.95e-05	0.000164	CcSEcCtD
Isradipine—Dermatitis—Gemcitabine—hematologic cancer	6.94e-05	0.000164	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—hematologic cancer	6.94e-05	0.000164	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—hematologic cancer	6.91e-05	0.000163	CcSEcCtD
Isradipine—Headache—Gemcitabine—hematologic cancer	6.9e-05	0.000163	CcSEcCtD
Isradipine—Nausea—Vincristine—hematologic cancer	6.9e-05	0.000163	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—hematologic cancer	6.89e-05	0.000162	CcSEcCtD
Isradipine—Flushing—Epirubicin—hematologic cancer	6.89e-05	0.000162	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—hematologic cancer	6.87e-05	0.000162	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—hematologic cancer	6.83e-05	0.000161	CcSEcCtD
Isradipine—Dyspepsia—Dexamethasone—hematologic cancer	6.82e-05	0.000161	CcSEcCtD
Isradipine—Dyspepsia—Betamethasone—hematologic cancer	6.82e-05	0.000161	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—hematologic cancer	6.78e-05	0.00016	CcSEcCtD
Isradipine—Urticaria—Triamcinolone—hematologic cancer	6.78e-05	0.00016	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—hematologic cancer	6.77e-05	0.00016	CcSEcCtD
Isradipine—Asthenia—Etoposide—hematologic cancer	6.75e-05	0.000159	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—hematologic cancer	6.75e-05	0.000159	CcSEcCtD
Isradipine—Oedema—Prednisone—hematologic cancer	6.74e-05	0.000159	CcSEcCtD
Isradipine—Anaphylactic shock—Prednisone—hematologic cancer	6.74e-05	0.000159	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—hematologic cancer	6.74e-05	0.000159	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—hematologic cancer	6.73e-05	0.000159	CcSEcCtD
Isradipine—Decreased appetite—Dexamethasone—hematologic cancer	6.73e-05	0.000159	CcSEcCtD
Isradipine—Decreased appetite—Betamethasone—hematologic cancer	6.73e-05	0.000159	CcSEcCtD
Isradipine—Nausea—Irinotecan—hematologic cancer	6.72e-05	0.000158	CcSEcCtD
Isradipine—Nausea—Mitoxantrone—hematologic cancer	6.72e-05	0.000158	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—hematologic cancer	6.71e-05	0.000158	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—hematologic cancer	6.69e-05	0.000158	CcSEcCtD
Isradipine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.69e-05	0.000158	CcSEcCtD
Isradipine—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.69e-05	0.000158	CcSEcCtD
Isradipine—Back pain—Methotrexate—hematologic cancer	6.68e-05	0.000157	CcSEcCtD
Isradipine—Fatigue—Betamethasone—hematologic cancer	6.68e-05	0.000157	CcSEcCtD
Isradipine—Fatigue—Dexamethasone—hematologic cancer	6.68e-05	0.000157	CcSEcCtD
Isradipine—Pruritus—Etoposide—hematologic cancer	6.66e-05	0.000157	CcSEcCtD
Isradipine—Shock—Prednisone—hematologic cancer	6.63e-05	0.000156	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—hematologic cancer	6.62e-05	0.000156	CcSEcCtD
Isradipine—Nervous system disorder—Prednisone—hematologic cancer	6.61e-05	0.000156	CcSEcCtD
Isradipine—Tachycardia—Prednisone—hematologic cancer	6.58e-05	0.000155	CcSEcCtD
Isradipine—Skin disorder—Prednisone—hematologic cancer	6.55e-05	0.000154	CcSEcCtD
Isradipine—Nausea—Gemcitabine—hematologic cancer	6.54e-05	0.000154	CcSEcCtD
Isradipine—Vomiting—Cisplatin—hematologic cancer	6.53e-05	0.000154	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisone—hematologic cancer	6.52e-05	0.000154	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—hematologic cancer	6.51e-05	0.000153	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—hematologic cancer	6.5e-05	0.000153	CcSEcCtD
Isradipine—Rash—Cisplatin—hematologic cancer	6.48e-05	0.000153	CcSEcCtD
Isradipine—Dermatitis—Cisplatin—hematologic cancer	6.47e-05	0.000153	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—hematologic cancer	6.46e-05	0.000152	CcSEcCtD
Isradipine—Diarrhoea—Etoposide—hematologic cancer	6.44e-05	0.000152	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—hematologic cancer	6.42e-05	0.000151	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—hematologic cancer	6.41e-05	0.000151	CcSEcCtD
Isradipine—Anaemia—Methotrexate—hematologic cancer	6.38e-05	0.00015	CcSEcCtD
Isradipine—Feeling abnormal—Dexamethasone—hematologic cancer	6.38e-05	0.00015	CcSEcCtD
Isradipine—Feeling abnormal—Betamethasone—hematologic cancer	6.38e-05	0.00015	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—hematologic cancer	6.37e-05	0.00015	CcSEcCtD
Isradipine—Flushing—Doxorubicin—hematologic cancer	6.37e-05	0.00015	CcSEcCtD
Isradipine—Tension—Epirubicin—hematologic cancer	6.34e-05	0.000149	CcSEcCtD
Isradipine—Nervousness—Epirubicin—hematologic cancer	6.28e-05	0.000148	CcSEcCtD
Isradipine—Back pain—Epirubicin—hematologic cancer	6.25e-05	0.000147	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—hematologic cancer	6.23e-05	0.000147	CcSEcCtD
Isradipine—Malaise—Methotrexate—hematologic cancer	6.23e-05	0.000147	CcSEcCtD
Isradipine—Dizziness—Etoposide—hematologic cancer	6.22e-05	0.000147	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—hematologic cancer	6.21e-05	0.000146	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—hematologic cancer	6.2e-05	0.000146	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—hematologic cancer	6.19e-05	0.000146	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—hematologic cancer	6.18e-05	0.000146	CcSEcCtD
Isradipine—Urticaria—Dexamethasone—hematologic cancer	6.15e-05	0.000145	CcSEcCtD
Isradipine—Urticaria—Betamethasone—hematologic cancer	6.15e-05	0.000145	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.14e-05	0.000145	CcSEcCtD
Isradipine—Dizziness—Prednisolone—hematologic cancer	6.14e-05	0.000145	CcSEcCtD
Isradipine—Asthenia—Triamcinolone—hematologic cancer	6.12e-05	0.000144	CcSEcCtD
Isradipine—Nausea—Cisplatin—hematologic cancer	6.1e-05	0.000144	CcSEcCtD
Isradipine—Insomnia—Prednisone—hematologic cancer	6.1e-05	0.000144	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—hematologic cancer	6.09e-05	0.000144	CcSEcCtD
Isradipine—Paraesthesia—Prednisone—hematologic cancer	6.06e-05	0.000143	CcSEcCtD
Isradipine—Pruritus—Triamcinolone—hematologic cancer	6.04e-05	0.000142	CcSEcCtD
Isradipine—Cough—Methotrexate—hematologic cancer	6.03e-05	0.000142	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—hematologic cancer	6.02e-05	0.000142	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—hematologic cancer	6e-05	0.000141	CcSEcCtD
Isradipine—Vomiting—Etoposide—hematologic cancer	5.98e-05	0.000141	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—hematologic cancer	5.98e-05	0.000141	CcSEcCtD
Isradipine—Anaemia—Epirubicin—hematologic cancer	5.97e-05	0.000141	CcSEcCtD
Isradipine—Dyspepsia—Prednisone—hematologic cancer	5.94e-05	0.00014	CcSEcCtD
Isradipine—Rash—Etoposide—hematologic cancer	5.93e-05	0.00014	CcSEcCtD
Isradipine—Dermatitis—Etoposide—hematologic cancer	5.93e-05	0.00014	CcSEcCtD
Isradipine—Headache—Etoposide—hematologic cancer	5.89e-05	0.000139	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—hematologic cancer	5.88e-05	0.000139	CcSEcCtD
Isradipine—Chest pain—Methotrexate—hematologic cancer	5.88e-05	0.000139	CcSEcCtD
Isradipine—Tension—Doxorubicin—hematologic cancer	5.87e-05	0.000138	CcSEcCtD
Isradipine—Decreased appetite—Prednisone—hematologic cancer	5.86e-05	0.000138	CcSEcCtD
Isradipine—Rash—Prednisolone—hematologic cancer	5.85e-05	0.000138	CcSEcCtD
Isradipine—Dermatitis—Prednisolone—hematologic cancer	5.85e-05	0.000138	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.84e-05	0.000138	CcSEcCtD
Isradipine—Malaise—Epirubicin—hematologic cancer	5.83e-05	0.000137	CcSEcCtD
Isradipine—Fatigue—Prednisone—hematologic cancer	5.81e-05	0.000137	CcSEcCtD
Isradipine—Headache—Prednisolone—hematologic cancer	5.81e-05	0.000137	CcSEcCtD
Isradipine—Discomfort—Methotrexate—hematologic cancer	5.81e-05	0.000137	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—hematologic cancer	5.81e-05	0.000137	CcSEcCtD
Isradipine—Syncope—Epirubicin—hematologic cancer	5.8e-05	0.000137	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—hematologic cancer	5.78e-05	0.000136	CcSEcCtD
Isradipine—Back pain—Doxorubicin—hematologic cancer	5.78e-05	0.000136	CcSEcCtD
Isradipine—Constipation—Prednisone—hematologic cancer	5.77e-05	0.000136	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—hematologic cancer	5.75e-05	0.000136	CcSEcCtD
Isradipine—Palpitations—Epirubicin—hematologic cancer	5.71e-05	0.000135	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—hematologic cancer	5.68e-05	0.000134	CcSEcCtD
Isradipine—Dizziness—Triamcinolone—hematologic cancer	5.64e-05	0.000133	CcSEcCtD
Isradipine—Cough—Epirubicin—hematologic cancer	5.64e-05	0.000133	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—hematologic cancer	5.64e-05	0.000133	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—hematologic cancer	5.64e-05	0.000133	CcSEcCtD
Isradipine—Nausea—Etoposide—hematologic cancer	5.59e-05	0.000132	CcSEcCtD
Isradipine—Feeling abnormal—Prednisone—hematologic cancer	5.56e-05	0.000131	CcSEcCtD
Isradipine—Asthenia—Dexamethasone—hematologic cancer	5.56e-05	0.000131	CcSEcCtD
Isradipine—Asthenia—Betamethasone—hematologic cancer	5.56e-05	0.000131	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—hematologic cancer	5.55e-05	0.000131	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—hematologic cancer	5.53e-05	0.00013	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—hematologic cancer	5.53e-05	0.00013	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—hematologic cancer	5.52e-05	0.00013	CcSEcCtD
Isradipine—Nausea—Prednisolone—hematologic cancer	5.51e-05	0.00013	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—hematologic cancer	5.5e-05	0.00013	CcSEcCtD
Isradipine—Chest pain—Epirubicin—hematologic cancer	5.5e-05	0.00013	CcSEcCtD
Isradipine—Anxiety—Epirubicin—hematologic cancer	5.48e-05	0.000129	CcSEcCtD
Isradipine—Pruritus—Dexamethasone—hematologic cancer	5.48e-05	0.000129	CcSEcCtD
Isradipine—Pruritus—Betamethasone—hematologic cancer	5.48e-05	0.000129	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—hematologic cancer	5.47e-05	0.000129	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.46e-05	0.000129	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—hematologic cancer	5.45e-05	0.000128	CcSEcCtD
Isradipine—Discomfort—Epirubicin—hematologic cancer	5.44e-05	0.000128	CcSEcCtD
Isradipine—Vomiting—Triamcinolone—hematologic cancer	5.43e-05	0.000128	CcSEcCtD
Isradipine—Malaise—Doxorubicin—hematologic cancer	5.39e-05	0.000127	CcSEcCtD
Isradipine—Rash—Triamcinolone—hematologic cancer	5.38e-05	0.000127	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—hematologic cancer	5.38e-05	0.000127	CcSEcCtD
Isradipine—Dermatitis—Triamcinolone—hematologic cancer	5.38e-05	0.000127	CcSEcCtD
Isradipine—Syncope—Doxorubicin—hematologic cancer	5.36e-05	0.000126	CcSEcCtD
Isradipine—Urticaria—Prednisone—hematologic cancer	5.36e-05	0.000126	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—hematologic cancer	5.35e-05	0.000126	CcSEcCtD
Isradipine—Headache—Triamcinolone—hematologic cancer	5.35e-05	0.000126	CcSEcCtD
Isradipine—Diarrhoea—Betamethasone—hematologic cancer	5.3e-05	0.000125	CcSEcCtD
Isradipine—Diarrhoea—Dexamethasone—hematologic cancer	5.3e-05	0.000125	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—hematologic cancer	5.28e-05	0.000125	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—hematologic cancer	5.27e-05	0.000124	CcSEcCtD
Isradipine—Oedema—Epirubicin—hematologic cancer	5.27e-05	0.000124	CcSEcCtD
Isradipine—Hypotension—Methotrexate—hematologic cancer	5.27e-05	0.000124	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—hematologic cancer	5.26e-05	0.000124	CcSEcCtD
Isradipine—Cough—Doxorubicin—hematologic cancer	5.22e-05	0.000123	CcSEcCtD
Isradipine—Shock—Epirubicin—hematologic cancer	5.19e-05	0.000122	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—hematologic cancer	5.17e-05	0.000122	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—hematologic cancer	5.16e-05	0.000122	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—hematologic cancer	5.15e-05	0.000121	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.13e-05	0.000121	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—hematologic cancer	5.12e-05	0.000121	CcSEcCtD
Isradipine—Dizziness—Dexamethasone—hematologic cancer	5.12e-05	0.000121	CcSEcCtD
Isradipine—Dizziness—Betamethasone—hematologic cancer	5.12e-05	0.000121	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—hematologic cancer	5.1e-05	0.00012	CcSEcCtD
Isradipine—Insomnia—Methotrexate—hematologic cancer	5.1e-05	0.00012	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—hematologic cancer	5.09e-05	0.00012	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—hematologic cancer	5.09e-05	0.00012	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—hematologic cancer	5.07e-05	0.00012	CcSEcCtD
Isradipine—Nausea—Triamcinolone—hematologic cancer	5.07e-05	0.000119	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—hematologic cancer	5.06e-05	0.000119	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.06e-05	0.000119	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—hematologic cancer	5.03e-05	0.000119	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—hematologic cancer	5.02e-05	0.000118	CcSEcCtD
Isradipine—Somnolence—Methotrexate—hematologic cancer	5.01e-05	0.000118	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—hematologic cancer	4.98e-05	0.000117	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—hematologic cancer	4.96e-05	0.000117	CcSEcCtD
Isradipine—Hypotension—Epirubicin—hematologic cancer	4.93e-05	0.000116	CcSEcCtD
Isradipine—Vomiting—Betamethasone—hematologic cancer	4.92e-05	0.000116	CcSEcCtD
Isradipine—Vomiting—Dexamethasone—hematologic cancer	4.92e-05	0.000116	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—hematologic cancer	4.9e-05	0.000115	CcSEcCtD
Isradipine—Rash—Dexamethasone—hematologic cancer	4.88e-05	0.000115	CcSEcCtD
Isradipine—Rash—Betamethasone—hematologic cancer	4.88e-05	0.000115	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—hematologic cancer	4.88e-05	0.000115	CcSEcCtD
Isradipine—Oedema—Doxorubicin—hematologic cancer	4.88e-05	0.000115	CcSEcCtD
Isradipine—Dermatitis—Dexamethasone—hematologic cancer	4.88e-05	0.000115	CcSEcCtD
Isradipine—Dermatitis—Betamethasone—hematologic cancer	4.88e-05	0.000115	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.87e-05	0.000115	CcSEcCtD
Isradipine—Fatigue—Methotrexate—hematologic cancer	4.86e-05	0.000115	CcSEcCtD
Isradipine—Headache—Dexamethasone—hematologic cancer	4.85e-05	0.000114	CcSEcCtD
Isradipine—Headache—Betamethasone—hematologic cancer	4.85e-05	0.000114	CcSEcCtD
Isradipine—Asthenia—Prednisone—hematologic cancer	4.84e-05	0.000114	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.81e-05	0.000113	CcSEcCtD
Isradipine—Shock—Doxorubicin—hematologic cancer	4.8e-05	0.000113	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—hematologic cancer	4.79e-05	0.000113	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—hematologic cancer	4.78e-05	0.000113	CcSEcCtD
Isradipine—Pruritus—Prednisone—hematologic cancer	4.77e-05	0.000112	CcSEcCtD
Isradipine—Insomnia—Epirubicin—hematologic cancer	4.77e-05	0.000112	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—hematologic cancer	4.76e-05	0.000112	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—hematologic cancer	4.74e-05	0.000112	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—hematologic cancer	4.74e-05	0.000112	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—hematologic cancer	4.72e-05	0.000111	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—hematologic cancer	4.7e-05	0.000111	CcSEcCtD
Isradipine—Somnolence—Epirubicin—hematologic cancer	4.69e-05	0.000111	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—hematologic cancer	4.64e-05	0.000109	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—hematologic cancer	4.64e-05	0.000109	CcSEcCtD
Isradipine—Diarrhoea—Prednisone—hematologic cancer	4.61e-05	0.000109	CcSEcCtD
Isradipine—Nausea—Betamethasone—hematologic cancer	4.6e-05	0.000108	CcSEcCtD
Isradipine—Nausea—Dexamethasone—hematologic cancer	4.6e-05	0.000108	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—hematologic cancer	4.58e-05	0.000108	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—hematologic cancer	4.56e-05	0.000107	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.55e-05	0.000107	CcSEcCtD
Isradipine—Fatigue—Epirubicin—hematologic cancer	4.55e-05	0.000107	CcSEcCtD
Isradipine—Constipation—Epirubicin—hematologic cancer	4.51e-05	0.000106	CcSEcCtD
Isradipine—Urticaria—Methotrexate—hematologic cancer	4.48e-05	0.000106	CcSEcCtD
Isradipine—Dizziness—Prednisone—hematologic cancer	4.46e-05	0.000105	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.45e-05	0.000105	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—hematologic cancer	4.41e-05	0.000104	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—hematologic cancer	4.38e-05	0.000103	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—hematologic cancer	4.35e-05	0.000103	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—hematologic cancer	4.35e-05	0.000102	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—hematologic cancer	4.34e-05	0.000102	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—hematologic cancer	4.3e-05	0.000101	CcSEcCtD
Isradipine—Vomiting—Prednisone—hematologic cancer	4.29e-05	0.000101	CcSEcCtD
Isradipine—Rash—Prednisone—hematologic cancer	4.25e-05	0.0001	CcSEcCtD
Isradipine—Dermatitis—Prednisone—hematologic cancer	4.25e-05	0.0001	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—hematologic cancer	4.24e-05	0.0001	CcSEcCtD
Isradipine—Headache—Prednisone—hematologic cancer	4.22e-05	9.96e-05	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.21e-05	9.93e-05	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—hematologic cancer	4.21e-05	9.92e-05	CcSEcCtD
Isradipine—Urticaria—Epirubicin—hematologic cancer	4.19e-05	9.88e-05	CcSEcCtD
Isradipine—Constipation—Doxorubicin—hematologic cancer	4.17e-05	9.84e-05	CcSEcCtD
Isradipine—Asthenia—Methotrexate—hematologic cancer	4.04e-05	9.53e-05	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—SRC—hematologic cancer	4.04e-05	0.000248	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	4.03e-05	0.000247	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—FGF2—hematologic cancer	4.03e-05	0.000247	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTT1—hematologic cancer	4.02e-05	0.000247	CbGpPWpGaD
Isradipine—Feeling abnormal—Doxorubicin—hematologic cancer	4.02e-05	9.48e-05	CcSEcCtD
Isradipine—CACNB2—Axon guidance—VEGFA—hematologic cancer	4.01e-05	0.000246	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAP2K1—hematologic cancer	4.01e-05	0.000246	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCG2—hematologic cancer	4.01e-05	0.000246	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—MTR—hematologic cancer	4.01e-05	0.000246	CbGpPWpGaD
Isradipine—Nausea—Prednisone—hematologic cancer	4.01e-05	9.44e-05	CcSEcCtD
Isradipine—Pruritus—Methotrexate—hematologic cancer	3.99e-05	9.4e-05	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—HRAS—hematologic cancer	3.98e-05	0.000245	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KRAS—hematologic cancer	3.98e-05	0.000244	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—NRAS—hematologic cancer	3.96e-05	0.000243	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC22A1—hematologic cancer	3.95e-05	0.000242	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CRABP1—hematologic cancer	3.95e-05	0.000242	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—VEGFA—hematologic cancer	3.93e-05	0.000241	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SDC1—hematologic cancer	3.93e-05	0.000241	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ENO2—hematologic cancer	3.93e-05	0.000241	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PTPN11—hematologic cancer	3.91e-05	0.00024	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—SRC—hematologic cancer	3.9e-05	0.000239	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—STAT3—hematologic cancer	3.9e-05	0.000239	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NRAS—hematologic cancer	3.89e-05	0.000238	CbGpPWpGaD
Isradipine—Urticaria—Doxorubicin—hematologic cancer	3.88e-05	9.14e-05	CcSEcCtD
Isradipine—CACNB2—Developmental Biology—JAK2—hematologic cancer	3.86e-05	0.000237	CbGpPWpGaD
Isradipine—Diarrhoea—Methotrexate—hematologic cancer	3.86e-05	9.09e-05	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—ABCB1—hematologic cancer	3.85e-05	0.000236	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALOX5—hematologic cancer	3.85e-05	0.000236	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—FGF2—hematologic cancer	3.81e-05	0.000234	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—IL6—hematologic cancer	3.81e-05	0.000234	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTT1—hematologic cancer	3.81e-05	0.000234	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—VEGFA—hematologic cancer	3.8e-05	0.000233	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MAPK3—hematologic cancer	3.79e-05	0.000233	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CREB1—hematologic cancer	3.79e-05	0.000233	CbGpPWpGaD
Isradipine—Asthenia—Epirubicin—hematologic cancer	3.78e-05	8.92e-05	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—NRAS—hematologic cancer	3.75e-05	0.00023	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTM1—hematologic cancer	3.74e-05	0.00023	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NCOR1—hematologic cancer	3.74e-05	0.00023	CbGpPWpGaD
Isradipine—Pruritus—Epirubicin—hematologic cancer	3.73e-05	8.8e-05	CcSEcCtD
Isradipine—CACNA1C—Metabolism—NUP98—hematologic cancer	3.73e-05	0.000229	CbGpPWpGaD
Isradipine—Dizziness—Methotrexate—hematologic cancer	3.73e-05	8.79e-05	CcSEcCtD
Isradipine—CACNA1D—Metabolism—SDC1—hematologic cancer	3.73e-05	0.000229	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MAPK3—hematologic cancer	3.72e-05	0.000228	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6R—hematologic cancer	3.7e-05	0.000227	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CREBBP—hematologic cancer	3.69e-05	0.000227	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—JAK2—hematologic cancer	3.66e-05	0.000224	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ADCY7—hematologic cancer	3.62e-05	0.000222	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NCOA3—hematologic cancer	3.62e-05	0.000222	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TGFB1—hematologic cancer	3.61e-05	0.000222	CbGpPWpGaD
Isradipine—Diarrhoea—Epirubicin—hematologic cancer	3.61e-05	8.51e-05	CcSEcCtD
Isradipine—CACNA1C—Metabolism—NUP214—hematologic cancer	3.59e-05	0.000221	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MAPK3—hematologic cancer	3.59e-05	0.000221	CbGpPWpGaD
Isradipine—Vomiting—Methotrexate—hematologic cancer	3.58e-05	8.45e-05	CcSEcCtD
Isradipine—Rash—Methotrexate—hematologic cancer	3.55e-05	8.38e-05	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—hematologic cancer	3.55e-05	8.37e-05	CcSEcCtD
Isradipine—Headache—Methotrexate—hematologic cancer	3.53e-05	8.32e-05	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—EP300—hematologic cancer	3.53e-05	0.000216	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAP2K1—hematologic cancer	3.52e-05	0.000216	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—MTR—hematologic cancer	3.52e-05	0.000216	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCG2—hematologic cancer	3.52e-05	0.000216	CbGpPWpGaD
Isradipine—Asthenia—Doxorubicin—hematologic cancer	3.5e-05	8.25e-05	CcSEcCtD
Isradipine—Dizziness—Epirubicin—hematologic cancer	3.49e-05	8.22e-05	CcSEcCtD
Isradipine—CACNA1C—Metabolism—ENO2—hematologic cancer	3.45e-05	0.000212	CbGpPWpGaD
Isradipine—Pruritus—Doxorubicin—hematologic cancer	3.45e-05	8.14e-05	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—SRC—hematologic cancer	3.43e-05	0.00021	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—SRC—hematologic cancer	3.43e-05	0.00021	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KRAS—hematologic cancer	3.41e-05	0.000209	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—hematologic cancer	3.38e-05	0.000207	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TNF—hematologic cancer	3.37e-05	0.000207	CbGpPWpGaD
Isradipine—Vomiting—Epirubicin—hematologic cancer	3.35e-05	7.9e-05	CcSEcCtD
Isradipine—CACNA1C—Developmental Biology—FGF2—hematologic cancer	3.35e-05	0.000206	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTT1—hematologic cancer	3.35e-05	0.000206	CbGpPWpGaD
Isradipine—Nausea—Methotrexate—hematologic cancer	3.35e-05	7.89e-05	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—KRAS—hematologic cancer	3.34e-05	0.000205	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NQO1—hematologic cancer	3.34e-05	0.000205	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CD44—hematologic cancer	3.34e-05	0.000205	CbGpPWpGaD
Isradipine—Diarrhoea—Doxorubicin—hematologic cancer	3.34e-05	7.87e-05	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—VEGFA—hematologic cancer	3.34e-05	0.000205	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—VEGFA—hematologic cancer	3.34e-05	0.000205	CbGpPWpGaD
Isradipine—Rash—Epirubicin—hematologic cancer	3.33e-05	7.84e-05	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—hematologic cancer	3.32e-05	7.83e-05	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—STAT3—hematologic cancer	3.31e-05	0.000203	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—MTHFR—hematologic cancer	3.31e-05	0.000203	CbGpPWpGaD
Isradipine—Headache—Epirubicin—hematologic cancer	3.3e-05	7.79e-05	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—NRAS—hematologic cancer	3.3e-05	0.000202	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—NRAS—hematologic cancer	3.3e-05	0.000202	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SDC1—hematologic cancer	3.27e-05	0.000201	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—hematologic cancer	3.27e-05	0.0002	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6—hematologic cancer	3.24e-05	0.000199	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KRAS—hematologic cancer	3.23e-05	0.000198	CbGpPWpGaD
Isradipine—Dizziness—Doxorubicin—hematologic cancer	3.23e-05	7.61e-05	CcSEcCtD
Isradipine—CACNA1C—Developmental Biology—JAK2—hematologic cancer	3.21e-05	0.000197	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NQO1—hematologic cancer	3.17e-05	0.000194	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CD44—hematologic cancer	3.17e-05	0.000194	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYCS—hematologic cancer	3.16e-05	0.000194	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MAPK3—hematologic cancer	3.16e-05	0.000194	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MAPK3—hematologic cancer	3.16e-05	0.000194	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HSP90AA1—hematologic cancer	3.14e-05	0.000193	CbGpPWpGaD
Isradipine—Nausea—Epirubicin—hematologic cancer	3.13e-05	7.38e-05	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—hematologic cancer	3.1e-05	7.31e-05	CcSEcCtD
Isradipine—Rash—Doxorubicin—hematologic cancer	3.08e-05	7.25e-05	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—hematologic cancer	3.07e-05	7.25e-05	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—TGFB1—hematologic cancer	3.06e-05	0.000188	CbGpPWpGaD
Isradipine—Headache—Doxorubicin—hematologic cancer	3.06e-05	7.21e-05	CcSEcCtD
Isradipine—CACNB2—Developmental Biology—EP300—hematologic cancer	3.02e-05	0.000185	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYCS—hematologic cancer	3e-05	0.000184	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HSP90AA1—hematologic cancer	2.98e-05	0.000183	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—SRC—hematologic cancer	2.94e-05	0.00018	CbGpPWpGaD
Isradipine—Nausea—Doxorubicin—hematologic cancer	2.9e-05	6.83e-05	CcSEcCtD
Isradipine—CACNB2—Axon guidance—HRAS—hematologic cancer	2.9e-05	0.000178	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—hematologic cancer	2.86e-05	0.000176	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EP300—hematologic cancer	2.86e-05	0.000176	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—hematologic cancer	2.86e-05	0.000176	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—hematologic cancer	2.84e-05	0.000174	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—hematologic cancer	2.84e-05	0.000174	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—hematologic cancer	2.84e-05	0.000174	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—STAT3—hematologic cancer	2.83e-05	0.000174	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NRAS—hematologic cancer	2.83e-05	0.000173	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.79e-05	0.000171	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTP1—hematologic cancer	2.79e-05	0.000171	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NQO1—hematologic cancer	2.78e-05	0.000171	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CD44—hematologic cancer	2.78e-05	0.000171	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—SRC—hematologic cancer	2.78e-05	0.000171	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CG—hematologic cancer	2.78e-05	0.00017	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—hematologic cancer	2.77e-05	0.00017	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.75e-05	0.000169	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—hematologic cancer	2.74e-05	0.000168	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—hematologic cancer	2.72e-05	0.000167	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—hematologic cancer	2.71e-05	0.000166	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK3—hematologic cancer	2.71e-05	0.000166	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—STAT3—hematologic cancer	2.68e-05	0.000165	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NRAS—hematologic cancer	2.68e-05	0.000164	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTP1—hematologic cancer	2.64e-05	0.000162	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ABCB1—hematologic cancer	2.64e-05	0.000162	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYCS—hematologic cancer	2.63e-05	0.000162	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—hematologic cancer	2.63e-05	0.000161	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TGFB1—hematologic cancer	2.63e-05	0.000161	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HSP90AA1—hematologic cancer	2.62e-05	0.000161	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CREBBP—hematologic cancer	2.58e-05	0.000158	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.57e-05	0.000158	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK3—hematologic cancer	2.56e-05	0.000157	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NCOR1—hematologic cancer	2.56e-05	0.000157	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTM1—hematologic cancer	2.56e-05	0.000157	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.53e-05	0.000155	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EP300—hematologic cancer	2.51e-05	0.000154	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—hematologic cancer	2.51e-05	0.000154	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCB1—hematologic cancer	2.5e-05	0.000153	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TGFB1—hematologic cancer	2.49e-05	0.000153	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—hematologic cancer	2.45e-05	0.000151	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—SRC—hematologic cancer	2.45e-05	0.00015	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CD—hematologic cancer	2.44e-05	0.00015	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—hematologic cancer	2.43e-05	0.000149	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTM1—hematologic cancer	2.43e-05	0.000149	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NCOR1—hematologic cancer	2.43e-05	0.000149	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—hematologic cancer	2.41e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—hematologic cancer	2.41e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALB—hematologic cancer	2.41e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—hematologic cancer	2.38e-05	0.000146	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—STAT3—hematologic cancer	2.36e-05	0.000145	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NRAS—hematologic cancer	2.35e-05	0.000144	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—hematologic cancer	2.32e-05	0.000143	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTP1—hematologic cancer	2.32e-05	0.000142	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—hematologic cancer	2.31e-05	0.000142	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—hematologic cancer	2.31e-05	0.000142	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3R1—hematologic cancer	2.31e-05	0.000141	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—hematologic cancer	2.3e-05	0.000141	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—MTHFR—hematologic cancer	2.27e-05	0.000139	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK3—hematologic cancer	2.25e-05	0.000138	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCB1—hematologic cancer	2.2e-05	0.000135	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TGFB1—hematologic cancer	2.19e-05	0.000134	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—MTHFR—hematologic cancer	2.15e-05	0.000132	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—FTCD—hematologic cancer	2.14e-05	0.000131	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PHYH—hematologic cancer	2.14e-05	0.000131	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GMPS—hematologic cancer	2.14e-05	0.000131	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTM1—hematologic cancer	2.13e-05	0.000131	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NCOR1—hematologic cancer	2.13e-05	0.000131	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—hematologic cancer	2.13e-05	0.000131	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CB—hematologic cancer	2.13e-05	0.000131	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—hematologic cancer	2.07e-05	0.000127	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—hematologic cancer	2.04e-05	0.000125	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—hematologic cancer	2.02e-05	0.000124	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—hematologic cancer	1.98e-05	0.000121	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—hematologic cancer	1.96e-05	0.00012	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.96e-05	0.00012	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CG—hematologic cancer	1.9e-05	0.000117	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—MTHFR—hematologic cancer	1.89e-05	0.000116	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—hematologic cancer	1.87e-05	0.000115	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTEN—hematologic cancer	1.84e-05	0.000113	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—hematologic cancer	1.83e-05	0.000112	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CG—hematologic cancer	1.8e-05	0.000111	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CREBBP—hematologic cancer	1.76e-05	0.000108	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—EP300—hematologic cancer	1.75e-05	0.000108	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—hematologic cancer	1.73e-05	0.000106	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—hematologic cancer	1.72e-05	0.000106	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—DCK—hematologic cancer	1.71e-05	0.000105	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.71e-05	0.000105	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.71e-05	0.000105	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CD—hematologic cancer	1.67e-05	0.000103	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CREBBP—hematologic cancer	1.67e-05	0.000103	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALB—hematologic cancer	1.65e-05	0.000101	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—hematologic cancer	1.65e-05	0.000101	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HDC—hematologic cancer	1.62e-05	9.95e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CD—hematologic cancer	1.58e-05	9.72e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CG—hematologic cancer	1.58e-05	9.72e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3R1—hematologic cancer	1.58e-05	9.7e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALB—hematologic cancer	1.56e-05	9.6e-05	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—hematologic cancer	1.52e-05	9.33e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3R1—hematologic cancer	1.5e-05	9.18e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CDA—hematologic cancer	1.48e-05	9.1e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CREBBP—hematologic cancer	1.47e-05	9.01e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CB—hematologic cancer	1.46e-05	8.95e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PC—hematologic cancer	1.43e-05	8.76e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CD—hematologic cancer	1.39e-05	8.54e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CB—hematologic cancer	1.38e-05	8.48e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GBA—hematologic cancer	1.38e-05	8.46e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.38e-05	8.46e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALB—hematologic cancer	1.37e-05	8.44e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3R1—hematologic cancer	1.31e-05	8.07e-05	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—hematologic cancer	1.3e-05	7.96e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTAP—hematologic cancer	1.26e-05	7.74e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTEN—hematologic cancer	1.26e-05	7.73e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CB—hematologic cancer	1.21e-05	7.45e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—EP300—hematologic cancer	1.2e-05	7.38e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTEN—hematologic cancer	1.19e-05	7.32e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—EP300—hematologic cancer	1.14e-05	6.99e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—FHL2—hematologic cancer	1.12e-05	6.9e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AGRN—hematologic cancer	1.1e-05	6.77e-05	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—hematologic cancer	1.06e-05	6.5e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTEN—hematologic cancer	1.05e-05	6.44e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HMMR—hematologic cancer	1.05e-05	6.41e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—IDH2—hematologic cancer	1.05e-05	6.41e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—EP300—hematologic cancer	1e-05	6.14e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.83e-06	6.03e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CA9—hematologic cancer	9.56e-06	5.87e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ACP5—hematologic cancer	9.56e-06	5.87e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.44e-06	5.79e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—IDH1—hematologic cancer	8.99e-06	5.52e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—hematologic cancer	8.89e-06	5.46e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TXN—hematologic cancer	8.89e-06	5.45e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.89e-06	5.45e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.89e-06	5.45e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.7e-06	5.34e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—hematologic cancer	8.42e-06	5.17e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.36e-06	5.13e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CRABP1—hematologic cancer	8.13e-06	4.99e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	8.13e-06	4.99e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.92e-06	4.86e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NUP98—hematologic cancer	7.67e-06	4.71e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.45e-06	4.57e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.45e-06	4.57e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—hematologic cancer	7.4e-06	4.54e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NUP214—hematologic cancer	7.4e-06	4.54e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—hematologic cancer	7.26e-06	4.46e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTR—hematologic cancer	7.25e-06	4.45e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.25e-06	4.45e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ENO2—hematologic cancer	7.11e-06	4.36e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.89e-06	4.23e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—hematologic cancer	6.88e-06	4.22e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SDC1—hematologic cancer	6.74e-06	4.13e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—hematologic cancer	6.04e-06	3.71e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CD44—hematologic cancer	5.73e-06	3.51e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NQO1—hematologic cancer	5.73e-06	3.51e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYCS—hematologic cancer	5.42e-06	3.33e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.38e-06	3.3e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.78e-06	2.93e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.52e-06	2.77e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.39e-06	2.69e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.39e-06	2.69e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.88e-06	2.38e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.26e-06	2e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.02e-06	1.85e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.87e-06	1.76e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALB—hematologic cancer	2.83e-06	1.74e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.71e-06	1.66e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.5e-06	1.53e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTEN—hematologic cancer	2.16e-06	1.32e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—EP300—hematologic cancer	2.06e-06	1.26e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.52e-06	9.34e-06	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.24e-06	7.63e-06	CbGpPWpGaD
